<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd"><ep-patent-document id="EP0870030A1" file="EP96944582NWA1.xml" lang="de" doc-number="0870030" date-publ="19981014" kind="A1" country="EP" status="n" dtd-version="ep-patent-document-v1-4"><SDOBI lang="de"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSE..PTIE......FI..........................................................</B001EP><B003EP>*</B003EP><B007EP>EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)</B007EP></eptags></B000><B100><B110>0870030</B110><B130>A1</B130><B140><date>19981014</date></B140><B190>EP</B190></B100><B200><B210>96944582.0</B210><B220><date>19961217</date></B220><B240><B241><date>19980722</date></B241></B240><B250>de</B250><B251EP>de</B251EP><B260>de</B260></B200><B300><B310>19951048295</B310><B320><date>19951222</date></B320><B330><ctry>DE</ctry></B330><B310>19961003492</B310><B320><date>19960131</date></B320><B330><ctry>DE</ctry></B330><B310>19961013866</B310><B320><date>19960406</date></B320><B330><ctry>DE</ctry></B330><B310>19961013886</B310><B320><date>19960406</date></B320><B330><ctry>DE</ctry></B330></B300><B400><B405><date>19981014</date><bnum>199842</bnum></B405><B430><date>19981014</date><bnum>199842</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07K  14/    54            A I                    </text></classification-ipcr><classification-ipcr sequence="2"><text>C12N   1/    21            A I                    </text></classification-ipcr><classification-ipcr sequence="3"><text>C12N  15/    24            A I                    </text></classification-ipcr><classification-ipcr sequence="4"><text>A61K  38/    00            A N                    </text></classification-ipcr></B510EP><B540><B541>en</B541><B542>POLYPEPTIDES WITH INTERLEUKIN 16 ACTIVITY, PROCESS FOR THE PREPARATION AND USE THEREOF</B542><B541>fr</B541><B542>POLYPEPTIDE A ACTIVITE D'IL-16, SON PROCEDE DE FABRICATION ET SON UTILISATION</B542><B541>de</B541><B542>POLYPEPTIDE MIT IL-16-AKTIVITÄT, VERFAHREN ZU IHRER HERSTELLUNG UND VERWENDUNG</B542></B540></B500><B700><B710><B711><snm>Bundesrepublik Deutschland vertreten durch den Bundesminister für Gesundheit</snm><adr><str /><city>53108 Bonn</city><ctry>DE</ctry></adr></B711><B711><snm>BOEHRINGER MANNHEIM GMBH</snm><adr><str>Sandhofer Strasse 112-132</str><city>68305 Mannheim</city><ctry>DE</ctry></adr></B711></B710><B720><B721><snm>KURTH, Reinhard</snm><adr><str>Erlenweg 4</str><city>D-63303 Dreieich</city><ctry>DE</ctry></adr></B721><B721><snm>BAIER, Michael</snm><adr><str>Eckenheimer Landstrasse 57a</str><city>D-60318 Frankfurt am Main</city><ctry>DE</ctry></adr></B721><B721><snm>BANNERT, Norbert</snm><adr><str>Adickesallee 13</str><city>D-60322 Frankfurt am Main</city><ctry>DE</ctry></adr></B721><B721><snm>METZNER, Karin</snm><adr><str>Brückenstrasse 17</str><city>D-60594 Frankfurt am Main</city><ctry>DE</ctry></adr></B721><B721><snm>WERNER, Albrecht</snm><adr><str>Prankelstrasse 30</str><city>D-69469 Weinheim</city><ctry>DE</ctry></adr></B721><B721><snm>LANG, Kurt</snm><adr><str>Langoner Strasse 10</str><city>D-82377 Penzberg</city><ctry>DE</ctry></adr></B721></B720><B740><B741><snm>Grussdorf, Jürgen, Dr.</snm><adr><str>Patentanwälte Zellentin &amp; Partner Rubensstrasse 30</str><city>67061 Ludwigshafen</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B860><B861><dnum><anum>EP1996005662</anum></dnum><date>19961217</date></B861><B862>de</B862></B860><B870><B871><dnum><pnum>WO1997023616</pnum></dnum><date>19970703</date><bnum>199729</bnum></B871></B870></B800></SDOBI></ep-patent-document>